GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXA1 | hg19_v2_chr14_-_38064198_38064239 | 0.43 | 5.2e-11 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_39684550 Show fit | 34.90 |
ENST00000455635.1
ENST00000361566.3 |
keratin 19 |
|
chr17_-_26695013 Show fit | 23.97 |
ENST00000555059.2
|
Homeobox protein SEBOX |
|
chr19_+_18496957 Show fit | 23.00 |
ENST00000252809.3
|
growth differentiation factor 15 |
|
chr17_-_26694979 Show fit | 22.84 |
ENST00000438614.1
|
vitronectin |
|
chr12_-_71551652 Show fit | 18.16 |
ENST00000546561.1
|
tetraspanin 8 |
|
chr12_-_71551868 Show fit | 16.82 |
ENST00000247829.3
|
tetraspanin 8 |
|
chr12_-_53343602 Show fit | 15.50 |
ENST00000546897.1
ENST00000552551.1 |
keratin 8 |
|
chr4_-_174256276 Show fit | 12.86 |
ENST00000296503.5
|
high mobility group box 2 |
|
chr7_+_73242490 Show fit | 12.52 |
ENST00000431918.1
|
claudin 4 |
|
chr7_+_116165754 Show fit | 12.47 |
ENST00000405348.1
|
caveolin 1, caveolae protein, 22kDa |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 47.8 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.7 | 44.2 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
1.0 | 23.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
2.5 | 22.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.2 | 22.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.7 | 17.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.1 | 14.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.1 | 14.2 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
1.3 | 12.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
4.2 | 12.5 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 129.8 | GO:0005615 | extracellular space(GO:0005615) |
7.8 | 46.6 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 45.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 43.2 | GO:0009986 | cell surface(GO:0009986) |
0.8 | 24.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 23.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
5.7 | 22.8 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.9 | 15.5 | GO:0042589 | zymogen granule membrane(GO:0042589) |
1.0 | 15.0 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 14.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 48.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 48.5 | GO:0005178 | integrin binding(GO:0005178) |
1.4 | 22.8 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 21.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 21.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 19.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 15.5 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.7 | 15.0 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.5 | 15.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.8 | 14.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 63.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.8 | 52.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 36.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 23.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 21.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 16.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 16.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 16.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.5 | 15.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 12.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 25.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.4 | 24.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 24.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 17.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.8 | 16.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 15.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 14.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.4 | 14.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.4 | 12.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.7 | 12.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |